#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital growth hormone deficiency Vascular malformation Infantile spasms Iron overload Hypotransferrinaemia Cystic fibrosis gastrointestinal disease Short-bowel syndrome Essential thrombocythaemia Breast angiosarcoma metastatic Cholangiosarcoma Thymic carcinoma Deafness bilateral Langerhans' cell histiocytosis Peritoneal neoplasm Fibrodysplasia ossificans progressiva More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Basic Information Skin angiosarcoma – Trials in Disease Rhabdomyosarcoma – Diagnostics Haemolytic uraemic syndrome – Diagnostics Crigler-Najjar syndrome – Basic Information Idiopathic pulmonary fibrosis – Basic Information Waldenstrom’s macroglobulinaemia recurrent Primary mediastinal large B-cell lymphoma – Life with Disease Hereditary motor and sensory neuropathy – Diagnostics Soft tissue sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cl-Ad-Msc-002 Mr0005 SOVATELTIDE Tozorakimab Pirtobrutinib Specific Nucleic Acid Sna-Ebv Eftrenonacog Alfa Dapagliflozin Methylone Fremanezumab Dexamethasone Argatroban Monohydrate Stiripentol Tamoxifen Methotrexate Disodium GT-002 Fluorouracil Mk-0482 Chlorpromazine Domperidone More therapies…

    Learn about Your Condition

    Ovarian cancer recurrent Astrocytoma malignant Craniocerebral injury Obstructive airways disorder Colitis ulcerative Rheumatoid arthritis Myasthenia gravis Myeloid leukaemia Mitral valve incompetence Obstructive pancreatitis Haemodialysis Stomatitis Pulmonary resection Malignant neoplasm of choroid Breast proliferative changes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sepsis

  • Study on the Effects of Immunoglobulin A, G, and M in Patients with Peritonitis and Sepsis After Infection Control

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritonitis
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Immunoglobulin A
    • Immunoglobulin G
    • Immunoglobulin M
    Austria Germany

  • Study of Aztreonam-Avibactam and Metronidazole for Children with Serious Gram-Negative Bacterial Infections

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial infection
    • Infection
    • Sepsis
    Investigated Drugs:
    • Amikacin
    • Avibactam Sodium
    • Colistimethate Sodium
    Czechia Greece Hungary Spain

  • Clarithromycin to prevent secondary infections in adult patients with community-acquired pneumonia-related sepsis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Clarithromycin
    • Water For Injection
    • Glucose Monohydrate
    Greece

  • Acetylcysteine for Adults with Acute Infection or Sepsis and Liver Dysfunction

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Infection
    • Sepsis
    Investigated Drugs:
    • Acetylcysteine
    • Sodium Chloride
    Denmark

  • Anakinra for Sepsis and Hyperinflammation in Pediatric Cancer Patients in the Intensive Care Unit

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Anakinra
    The Netherlands

  • A study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bacterial infection
    • Sepsis
    Investigated Drugs:
    • Meropenem Anhydrous
    • Sodium Chloride
    Greece
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!